Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study.
- DOI
- 10.1016/j.cllc.2026.02.001
- Published
- 2026 Apr
- Container
- Clinical lung cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2026.02.001,
title = {Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study.},
author = {Minchom A and Cho BC and Leighl NB and Johnson ML and Sabari J and Lee SH and Lee KH and Kim YJ and Sanborn RE and O'Neil B and Sankar K and Mitselos A and Zemlickis D and Collins C and Alhadab A and Clemens PL and Sanusi B and Berkay E and Baig M and Knoblauch RE and Hellemans P and Krebs MG},
year = {2026},
journal = {Clinical lung cancer},
doi = {10.1016/j.cllc.2026.02.001},
url = {https://doi.org/10.1016/j.cllc.2026.02.001}
}RIS
TY - JOUR TI - Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study. AU - Minchom A AU - Cho BC AU - Leighl NB AU - Johnson ML AU - Sabari J AU - Lee SH AU - Lee KH AU - Kim YJ AU - Sanborn RE AU - O'Neil B AU - Sankar K AU - Mitselos A AU - Zemlickis D AU - Collins C AU - Alhadab A AU - Clemens PL AU - Sanusi B AU - Berkay E AU - Baig M AU - Knoblauch RE AU - Hellemans P AU - Krebs MG PY - 2026 JO - Clinical lung cancer DO - 10.1016/j.cllc.2026.02.001 UR - https://doi.org/10.1016/j.cllc.2026.02.001 ER -
APA
A, M., BC, C., NB, L., ML, J., J, S., SH, L., KH, L., YJ, K., RE, S., B, O., K, S., A, M., D, Z., C, C., A, A., PL, C., B, S., E, B., M, B., RE, K., P, H., & MG, K. (2026). Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2026.02.001
Source records
- pubmed · retrieved 2026-09-26T07:19:29.423Z